This inventor holds 2 USPTO granted patents. Top assignees: Hylapharm, LLC, University of Kansas. Active years: 2022-2025.
Company Filing History:
2 out of 2 
2 out of 571 
Years Active: 2022-2025
Title: Ruolin Lu: Innovator in Cancer Treatment and Vaccine Development
Introduction
Ruolin Lu is a prominent inventor based in Lawrence, KS (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for cancer treatment and vaccine adjuvants. With a total of 2 patents, her work is paving the way for innovative therapeutic solutions.
Latest Patents
One of her latest patents is focused on imidazoquinoline compounds and prodrugs thereof. This technology is directed to TLR7 and TLR8 agonist compounds, compositions, and methods of using them for the treatment of cancers and as vaccine adjuvants. Another notable patent involves platinum(IV) conjugates and methods of use. This patent provides platinum(IV) compounds of Formula I or pharmaceutically acceptable salts, along with compositions that include such compounds and methods for their use.
Career Highlights
Throughout her career, Ruolin Lu has worked with esteemed organizations such as the University of Kansas and Hylapharm, LLC. Her experience in these institutions has allowed her to advance her research and contribute to the scientific community.
Collaborations
Some of her notable coworkers include Peter Kleindl and Laird Forrest. Their collaboration has further enriched her research endeavors and innovations.
Conclusion
Ruolin Lu's work exemplifies the spirit of innovation in the pharmaceutical industry. Her patents and collaborations are instrumental in advancing treatments for cancer and enhancing vaccine efficacy.